CTOs on the Move

Suek AG

www.suekag.com

 
SUEK AG was established in December 2004 as an exclusive exporting company of SUEK Group, the largest Russian coal producer which consolidates mining, logistics and distributing assets. We are one of the biggest suppliers of Russian coal to the international market. SUEK AG delivers coal to more than 40 countries worldwide. Our preferred goal is to develop direct relationships with consumers and as such, more than 80% of our sales are made directly to the end-users.
  • Number of Employees: 1K-5K
  • Annual Revenue: $10-50 Million
  • www.suekag.com
  • 1680 Michigan Avenue Suite 700
    Miami Beach, FL USA 33139
  • Phone: 305.308.4064

Executives

Name Title Contact Details

Similar Companies

Vista Research

Vista Research is a New York, NY-based company in the Business Services sector.

BRG Research Services

BRG Research Services is a Provo, UT-based company in the Business Services sector.

Arcus

Arcus is a Hummelstown, PA-based company in the Business Services sector.

Procon Pacific, LLC

Procon Pacific is a global FIBC sourcing and procurement consulting firm. We offer a range of FIBC components, finished goods, and other semi-bulk packaging products to our clients. Through proven supply chain partnerships and the completion of one of the worlds largest FIBC production facilities in April of 2007, Procon Pacific is able to provide world class packaging products and on time delivery where and when it is needed across the globe.

TriLink BioTechnologies, part of Maravai LifeSciences

TriLink BioTechnologies, part of Maravai LifeSciences, is a prominent contract development and manufacturing organization (CDMO) based in San Diego. Founded in 1996, the company specializes in the synthesis of nucleic acids, nucleoside triphosphates (NTPs), and mRNA capping analogs. TriLink provides advanced scale-up expertise and unique production capabilities for mRNA, oligonucleotides, and plasmids, catering to clients in therapeutics, vaccines, diagnostics, and biopharmaceutical innovations. The company offers custom synthesis and manufacturing services, supporting clients from early research through clinical trials. TriLinks proprietary CleanCap® technology enhances mRNA manufacturing efficiency, resulting in improved yields. Their product portfolio includes custom and modified oligonucleotides, plasmids, mRNA, and CleanCap® reagents. TriLink adheres to stringent quality systems compliant with ICH Q7, GMP guidelines, and ISO 9001:2015 standards, ensuring high-quality manufacturing for a diverse range of applications. The company collaborates with various organizations, including the U.S. Department of Defense, to support the development of critical mRNA vaccines and therapeutics.